RxDoctor Payments Data

Cooper Stewart, MD

Family Medicine · Wellington, KSNPI 1699123901

Payments from drug & device makers

$482in general payments, 2019–2025

Across 34 payments — averaging $14.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$121
  • AstraZeneca$49
  • Merck$46
  • Teva Pharmaceuticals USA, Inc.$43
  • Novo Nordisk$41
  • Johnson & Johnson$29
  • plus $154 from 10 others

What the payments were for

  • Food & beverage$482100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$482 in reported general payments places this provider in the 45th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$5,133
Medicare patients
100
Services billed
358

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban109$83,515
JardianceEmpagliflozin84$64,485
OzempicSemaglutide60$62,536
FarxigaDapagliflozin Propanediol39$37,466
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$32,829
JanuviaSitagliptin Phosphate48$32,245
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr60$28,503
Spiriva RespimatTiotropium Bromide38$26,056
XareltoRivaroxaban16$22,949
Erythromycin Ethylsuccinate12$19,451
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog22$19,082
Tresiba Flextouch U-100Insulin Degludec45$17,717
Novolog FlexpenInsulin Aspart77$16,654
MyrbetriqMirabegron33$16,218
MounjaroTirzepatide13$13,580

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$24$83,515109 claims
Novo NordiskOzempic$41$62,53660 claims
AstraZenecaFarxiga, Breztri Aerosphere$49$45,96054 claims
MerckJanuvia$46$32,24548 claims
Johnson & JohnsonXarelto$29$22,94916 claims
Astellas Pharma US IncMyrbetriq$15$16,21833 claims
Lilly USA, LLCMounjaro$13$13,58013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Wellington

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →